These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2686350)
21. Histopathological changes in the liver after allogeneic bone marrow transplantation. Sloane JP; Farthing MJ; Powles RL J Clin Pathol; 1980 Apr; 33(4):344-50. PubMed ID: 6995486 [TBL] [Abstract][Full Text] [Related]
22. Histological changes of the liver in experimental graft-versus-host disease across minor histocompatibility barriers. VII. A light and electron microscopic study of the large bile duct. Nonomura A; Kono N; Mizukami Y; Nakanuma Y Liver; 1993 Jun; 13(3):163-71. PubMed ID: 8336528 [TBL] [Abstract][Full Text] [Related]
23. An immunohistological study of human hepatic graft-versus-host disease. Dilly SA; Sloane JP Clin Exp Immunol; 1985 Dec; 62(3):545-53. PubMed ID: 3910317 [TBL] [Abstract][Full Text] [Related]
24. The aberrant expression of HLA-DR in intrahepatic bile ducts in patients with biliary atresia: an immunohistochemistry and immune electron microscopy study. Feng J; Li M; Gu W; Tang H; Yu S J Pediatr Surg; 2004 Nov; 39(11):1658-62. PubMed ID: 15547830 [TBL] [Abstract][Full Text] [Related]
25. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation. Dermime S; Mavroudis D; Jiang YZ; Hensel N; Molldrem J; Barrett AJ Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643 [TBL] [Abstract][Full Text] [Related]
26. Histological changes in the liver in experimental graft-versus-host disease across minor histocompatibility barriers. VI. A light and electron microscopic study of the periportal changes. Nonomura A; Kono N; Mizukzmi Y; Nakanuma Y; Matsubara F Liver; 1991 Oct; 11(5):278-86. PubMed ID: 1961089 [TBL] [Abstract][Full Text] [Related]
27. Histological changes of bile duct in experimental graft-versus-disease across minor histocompatibility barriers. III. Immunoelectron microscopic observations. Nonomura A; Yoshida K; Kono N; Nakanuma Y; Ohta G Acta Pathol Jpn; 1988 Mar; 38(3):269-80. PubMed ID: 2969170 [TBL] [Abstract][Full Text] [Related]
29. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Ayres RC; Neuberger JM; Shaw J; Joplin R; Adams DH Gut; 1993 Sep; 34(9):1245-9. PubMed ID: 8104850 [TBL] [Abstract][Full Text] [Related]
30. Current problems with intrahepatic bile duct stones in Japan--congenital biliary malformations as a cause. Fujii H; Yang Y; Matsumoto Y; Suda K Hepatogastroenterology; 1997; 44(14):328-41. PubMed ID: 9164499 [TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Saperstein LA; Jirtle RL; Farouk M; Thompson HJ; Chung KS; Meyers WC Hepatology; 1994 Feb; 19(2):412-7. PubMed ID: 8294098 [TBL] [Abstract][Full Text] [Related]
32. Immunoelectron microscopic localization of MHC class 1 and 2 antigens on bile duct epithelial cells in patients with primary biliary cirrhosis. Nishimoto H; Yamada G; Mizuno M; Tsuji T Acta Med Okayama; 1994 Dec; 48(6):317-22. PubMed ID: 7709759 [TBL] [Abstract][Full Text] [Related]
34. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells. Williams FH; Thiele DL Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273 [TBL] [Abstract][Full Text] [Related]
35. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation. Le Deist F; Raffoux C; Griscelli C; Fischer A J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121 [TBL] [Abstract][Full Text] [Related]
36. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
37. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631 [TBL] [Abstract][Full Text] [Related]
39. Expression of HLA-DR antigens on interlobular bile ducts in primary biliary cirrhosis and other hepatobiliary diseases: an immunohistochemical study. Nakanuma Y; Kono N Hum Pathol; 1991 May; 22(5):431-6. PubMed ID: 2032692 [TBL] [Abstract][Full Text] [Related]
40. Donor helper T-cell frequencies as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. Weston LE; Geczy AF; Farrell C Transplantation; 1997 Sep; 64(6):836-41. PubMed ID: 9326407 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]